Overview
Scott Lippman is an Oncologist in Houston, Texas. Dr. Lippman is highly rated in 6 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), EGFR Positive Lung Cancer, and Tissue Biopsy.
His clinical research consists of co-authoring 196 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
MD Anderson
Hagop Kantarjian is an Oncologist and a Hematologist in Houston, Texas. Dr. Kantarjian is highly rated in 47 conditions, according to our data. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.
MD Anderson
Naveen Pemmaraju is an Oncologist and a Hematologist in Houston, Texas. Dr. Pemmaraju is highly rated in 35 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelofibrosis, Bone Marrow Aspiration, and Bone Marrow Transplant.
MD Anderson
Neeta Somaiah is an Oncologist in Houston, Texas. Dr. Somaiah is highly rated in 28 conditions, according to our data. Her top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Hepato-Pancreato-Biliary Surgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Lippman isDistinguished. Learn about Lung Cancer.
- Advanced
- EGFR Positive Lung CancerDr. Lippman isAdvanced. Learn about EGFR Positive Lung Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung AdenocarcinomaDr. Lippman isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Lippman isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pancreatic CancerDr. Lippman isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Adenoid Cystic CarcinomaDr. Lippman isExperienced. Learn about Adenoid Cystic Carcinoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Lippman isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Lippman isExperienced. Learn about Anal Cancer.
- Breast CancerDr. Lippman isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Lippman isExperienced. Learn about Colorectal Cancer.
- Esophageal CancerDr. Lippman isExperienced. Learn about Esophageal Cancer.